Aegis Evolutionary Chemistry, a component of Aegis BioMedical Biotechnologies, is devoted to bringing high quality, medicinally useful natural product-based therapeutics to market. We provide guidance on product formulation and chemistry, targeting disease applications and patient populations, and validating the full product cycle from analytical chemistry to user feedback. Our primary focus is developing novel cannabis-based therapies with the dual goals of addressing unmet medical needs and providing safer alternatives to available medications. We have a deep understanding of the science of cannabinoids and the human endocannabinoid system, as well as the regulatory and business landscape in California. The mission of Aegis Evolutionary Chemistry is to leverage our knowledge, experience and networks to provide successful molecule-to-market guidance in this exciting emerging field.
Full design, development and execution of cannabis or hemp-based therapeutic product production. We combine our vetted network of suppliers and manufacturers on the Globally with deep scientific expertise in analytical chemistry and natural product therapeutics. Product Strategies from molecule to market.
I specialize in the design and execution of analytical chemistry projects with biomedical or therapeutic goals. I have extensive experience in natural product drug development, particularly mass spectrometry, HPLC and cellular assays.
interpretation of laboratory testing results, particularly mass spectrometry and UV HPLC
specializing cannabinoid and terpene analysis for the cannabis industry
"I like Aegis Biotech. I do not like Science Exchange. They messed up my payment by not adding the vendor fee and the Science Exchange fee correctly Then the SciEx portal makes it difficult to understand what is happening with my project. I am not impressed."
Aegis Evolutionary Chemistry has not received any endorsements.